{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:38:49Z","timestamp":1763181529821,"version":"3.45.0"},"reference-count":37,"publisher":"Japanese Society for Hygiene","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Environ. Health Prev. Med.","Environ Health Prev Med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1265\/ehpm.25-00022","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T22:09:21Z","timestamp":1763158161000},"page":"88-88","source":"Crossref","is-referenced-by-count":0,"title":["Interaction between CYP3A4 gene polymorphism and obesity on breast cancer susceptibility in Chinese women"],"prefix":"10.1265","volume":"30","author":[{"given":"Jiamin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Oncology, the Affiliated Jiangyin Hospital of Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baixia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Tumor Hospital, Tumor Hospital Affiliated to Nantong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Nantong Rici Hospital Affiliated to Yangzhou University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"335","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341.","DOI":"10.3322\/caac.21754"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tao X, Li T, Gandomkar Z, Brennan PC, Reed WM. Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries. Asia Pac J Clin Oncol. 2023;19(6):645\u201354.","DOI":"10.1111\/ajco.13958"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lei S, Zheng R, Zhang S, Chen R, Wang S, Sun K, Zeng H, Wei W, He J. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med. 2021;18(3):900\u20139.","DOI":"10.20892\/j.issn.2095-3941.2020.0523"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Green VL. Breast Cancer Risk Assessment and Management of the High-Risk Patient. Obstet Gynecol Clin North Am. 2022;49(1):87\u2013116.","DOI":"10.1016\/j.ogc.2021.11.009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003;82(3):191\u20137.","DOI":"10.1023\/B:BREA.0000004376.21491.44"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003;144(8):3382\u201398.","DOI":"10.1210\/en.2003-0192"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mokhosoev IM, Astakhov DV, Terentiev AA, Moldogazieva NT. Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review. Cells. 2024;13(23):1958.","DOI":"10.3390\/cells13231958"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD. Profiling the expression of cytochrome P450 in breast cancer. Histopathology. 2010;57(2):202\u201311.","DOI":"10.1111\/j.1365-2559.2010.03606.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Al-Eitan LN, Rababa\u2019h DM, Alghamdi MA, Khasawneh RH. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC Med Genet. 2019;20(1):148.","DOI":"10.1186\/s12881-019-0884-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Parada H Jr, Steck SE, Cleveland RJ, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence. Ann Epidemiol. 2017;27(3):208\u201314.e1.","DOI":"10.1016\/j.annepidem.2016.11.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103\u201341.","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"13","unstructured":"13. Kadlubar FF, Berkowitz GS, Delongchamp RR, et al. The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:327\u201331."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tsai SM, Lin CY, Wu SH, et al. Side effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphisms. Clin Chim Acta. 2009;404:160\u20135.","DOI":"10.1016\/j.cca.2009.03.038"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341.","DOI":"10.3322\/caac.21754"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Naaman SC, Shen S, Zeytinoglu M, Iyengar NM. Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation. J Clin Endocrinol Metab. 2022;107(8):2154\u201366.","DOI":"10.1210\/clinem\/dgac241"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ye H, Tang LY, Liang ZZ, Chen QX, Li YQ, Liu Q, Xie X, Lin Y, Ren ZF. Effects of Infection-Induced Fever and the Interaction with IL6 rs1800796 Polymorphism on the Prognosis of Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(11):2030\u20137.","DOI":"10.1158\/1055-9965.EPI-22-0498"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Adolf IC, Rweyemamu LP, Akan G, Mselle TF, Dharsee N, Namkinga LA, Lyantagaye SL, Atalar F. The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. Cancer Med. 2023;12(1):472\u201387.","DOI":"10.1002\/cam4.4914"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rothschild HT, Abel MK, Patterson A, Goodman K, Shui A, van Baelen K, Desmedt C, Benz C, Mukhtar RA. Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Res Treat. 2022;191(2):451\u20138.","DOI":"10.1007\/s10549-021-06453-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nam GE, Zhang ZF, Rao J, Zhou H, Jung SY. Interactions Between Adiponectin-Pathway Polymorphisms and Obesity on Postmenopausal Breast Cancer Risk Among African American Women: The WHI SHARe Study. Front Oncol. 2021;11:698198.","DOI":"10.3389\/fonc.2021.698198"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Xu S, Zhou Y, Du WD, Chen G, Zhou FS, Schneider M, Ma XL, Xu HY, Zhang XJ. Association of the variant rs2243421 of human DOC-2\/DAB2 interactive protein gene (hDAB2IP) with gastric cancer in the Chinese Han population. Gene. 2013;515(1):200\u20134.","DOI":"10.1016\/j.gene.2012.11.043"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim Y, Park T. Robust Gene-Gene Interaction Analysis in Genome Wide Association Studies. PLoS One. 2015;10(8):e0135016.","DOI":"10.1371\/journal.pone.0135016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hu GX, Dai DP, Wang H, Huang XX, Zhou XY, Cai J, Chen H, Cai JP. Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population. Pharmacogenomics. 2017;18(4):369\u201379.","DOI":"10.2217\/pgs-2016-0179"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chau Chau CH, Price DK, Till C, Goodman PJ, Chen X, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Tangen CM, Chu L, Parnes HL, Schenk JM, Reichardt JK, Thompson IM, Figg WD. Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PLoS One. 2015;10(5):e0126672.","DOI":"10.1371\/journal.pone.0126672"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pascual T, Apell\u00e1niz-Ruiz M, Pernaut C, Cueto-Felgueroso C, Villalba P, \u00c1lvarez C, Manso L, Inglada-P\u00e9rez L, Robledo M, Rodr\u00edguez-Antona C, Ciruelos E. Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer. PLoS One. 2017;12(7):e0180192.","DOI":"10.1371\/journal.pone.0180192"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Fiszer-Maliszewska \u0141, \u0141aczma\u0144ski \u0141, Doli\u0144ska A, Jagas M, Ko\u0142odziejska E, Jankowska M, Ku\u015bnierczyk P. Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles. Anticancer Res. 2018;38(3):1455\u20139.","DOI":"10.21873\/anticanres.12370"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1998\u20132003.","DOI":"10.1158\/1055-9965.EPI-05-0076"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Johnson N, Walker K, Gibson LJ, Orr N, Folkerd E, Haynes B, Palles C, Coupland B, Schoemaker M, Jones M, Broderick P, Sawyer E, Kerin M, Tomlinson IP, Zvelebil M, Chilcott-Burns S, Tomczyk K, Simpson G, Williamson J, Hillier SG, Ross G, Houlston RS, Swerdlow A, Ashworth A, Dowsett M, Peto J, Dos Santos Silva I, Fletcher O. CYP3A variation, premenopausal estrone levels, and breast cancer risk. J Natl Cancer Inst. 2012;104(9):657\u201369.","DOI":"10.1093\/jnci\/djs156"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Liu X, Huang X, Zhang S, Niu F, Ouyang Y, Shou Z, Liu J. Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population. Int J Clin Oncol. 2019;24(2):179\u201388.","DOI":"10.1007\/s10147-018-1346-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Veiga MG, Felizi RT, Reis DG, Carelli Filho I, Fernandes CE, Souto RPD, Oliveira E. The Influence of CYP3A4 Polymorphism in Sex Steroids as a Risk Factor for Breast Cancer. Rev Bras Ginecol Obstet. 2018;40(11):699\u2013704.","DOI":"10.1055\/s-0038-1673365"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Brockstedt U, Krajinovic M, Richer C, Mathonnet G, Sinnett D, Pfau W, Labuda D. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutat Res. 2002;516(1\u20132):41\u20137.","DOI":"10.1016\/S1383-5718(02)00019-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Key T, Appleby P, Barnes I, Reeves G; Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002 Apr;94(8):606\u201316.","DOI":"10.1093\/jnci\/94.8.606"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Nithipatikom K, Brody DM, Tang AT, Manthati VL, Falck JR, Williams CL, Campbell WB. Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists. Cancer Sci. 2010;101(12):2629\u201336.","DOI":"10.1111\/j.1349-7006.2010.01713.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Keshava C, McCanlies EC, Weston A. CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review. Am J Epidemiol. 2004;160(9):825\u201341.","DOI":"10.1093\/aje\/kwh294"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wu J, Wang S, Liu F, Li S. Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women. Clin Breast Cancer. 2018;18(3):e329\u201333.","DOI":"10.1016\/j.clbc.2017.09.003"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Epigenetics in breast cancer: what\u2019s new? Breast Cancer Res. 2011;13(6):225.","DOI":"10.1186\/bcr2925"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Doaei S, Bourbour F, Rastgoo S, Akbari ME, Gholamalizadeh M, Hajipour A, Moslem A, Ghorat F, Badeli M, Bagheri SE, Alizadeh A, Mokhtari Z, Pishdad S, JavadiKooshesh S, Azizi Tabesh G, Montazeri F, Joola P, Rezaei S, Dorosti M, Mosavi Jarrahi SA. Interactions of anthropometric indices, rs9939609 FTO gene polymorphism and breast cancer: A case-control study. J Cell Mol Med. 2021;25(7):3252\u20137.","DOI":"10.1111\/jcmm.16394"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_25-00022\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:35:37Z","timestamp":1763181337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ehpm\/30\/0\/30_25-00022\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1265\/ehpm.25-00022","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"type":"print","value":"1342-078X"},{"type":"electronic","value":"1347-4715"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-00022"}}